"We are making substantial progress in the fight against dementia," write Drs. Murali Doraiswamy and Eric Stallard.
A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...
The new test by Washington University School of Medicine can help doctors determine which patients are likely to benefit from ...
A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...
A new "highly accurate" blood test for Alzheimer's disease also measures how far it has progressed. It could help enable ...
This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
Medical Xpress on MSN12d
Experimental drug shows promise in reducing risk of Alzheimer's-related dementiaAn experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the ... ARIA ...
A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it ...
New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...
A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have ...
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results